μMESH-Enabled Sustained Delivery of Molecular and Nanoformulated Drugs for Glioblastoma Treatment

[Image: see text] Modest tissue penetrance, nonuniform distribution, and suboptimal release of drugs limit the potential of intracranial therapies against glioblastoma. Here, a conformable polymeric implant, μMESH, is realized by intercalating a micronetwork of 3 × 5 μm poly(lactic-co-glycolic acid)...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Mascolo, Daniele, Guerriero, Irene, Pesce, Cristiano, Spanò, Raffaele, Palange, Anna Lisa, Decuzzi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416560/
https://www.ncbi.nlm.nih.gov/pubmed/37379253
http://dx.doi.org/10.1021/acsnano.3c01574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416560/
https://www.ncbi.nlm.nih.gov/pubmed/37379253
http://dx.doi.org/10.1021/acsnano.3c01574

Ejemplares similares